Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held on Friday, February 5, 2021, considered and approved the following proposals: Appointment of Pramod Yadav as Non-executive Non-independent Director of the Company effective from February 5, 2021. Brief profile of Yadav is given as Annexure-A to this letter. Yadav is not related to any Director of the Company; and resignation of Rajesh Kumar Srivastava and Anant Pande as Director and Whole-time Director of the Company effective from the close of business hours of February 5, 2021. The above change in composition of the Board of Directors of the Company is on account of demerger of the Life Science Ingredients business of the Company into the Resulting Company, Jubilant Ingrevia, pursuant to the Composite Scheme of Arrangement.
The above information is a part of company’s filings submitted to BSE.
